While state Medicaid programs must cover nearly all Food and Drug Administration (FDA) approved drugs, a long-standing statutory exception allows states to choose whether to cover weight-loss drugs under Medicaid
But insurance companies want to keep costs down themselves, so many won't cover them for weight loss, or require patients to jump through frustrating hoops to get approval for coverage
Compared to international vendors where shipping might be $50+ and carry the risk of customs seizure, the "all-in" price from Core Peptides often ends up being more economical and far less stressful for the recipient
Research-Aware Clients Biohackers and early adopters who want accurate, medically responsible guidance instead of risky online sourcing
One-third (31%) know of someone who has taken a GLP-1 for weight loss and 22% for Type 2 diabetes
The MHRA has issued important safety warnings regarding pioglitazone, including risks of fluid retention and heart failure, increased fracture risk (particularly in women), and a potential bladder cancer signal